Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2026 09:00 ET | Source: Stipple Bio, Inc.

Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies

– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform — — Stipple Bio’s Pointillist Platform identifies...
June 04, 2026 08:55 ET | Source: Command Alkon Incorporated

Command Alkon's Command Cloud Platform Recognized as Silver Globee® Winner in 2026 Globee® Awards for Pioneers

HILLIARD, Ohio, June 04, 2026 (GLOBE NEWSWIRE) -- Command Alkon is proud to announce that its Command Cloud Platform has been recognized as a Silver Globee® Winner in the 6th Annual 2026 Globee®...
June 04, 2026 08:33 ET | Source: LincNutri

LincNutri Launches KSM-66 Ashwagandha Complex, a Multi-Layer Adaptogen Formula for Modern Stress and Focus

LincNutri's KSM-66 Ashwagandha Complex blends adaptogens like L-Theanine, Ginseng, and Ginkgo for calm focus, energy, and stress relief. On Amazon now.
June 04, 2026 08:30 ET | Source: SS Innovations

SS Innovations Announces Completion of World’s Longest-Distance Robotic Telesurgery

SS Innovations Announces Completion of World’s Longest-Distance Robotic Telesurgery
June 04, 2026 08:30 ET | Source: Satellogic, Inc.

Satellogic Appoints Lieutenant General (Ret.) Michael E. Williamson to its Board of Directors

Satellogic Appoints Lieutenant General (Ret.) Michael E. Williamson to its Board of Directors
June 04, 2026 08:30 ET | Source: TechMediaWire

Factory-Built Housing Gains Momentum as Supply Crisis Deepens

AUSTIN, Texas, June 04, 2026 (GLOBE NEWSWIRE) -- TechMediaWire Editorial Coverage: The U.S. housing market continues grappling with mounting affordability concerns and a persistent lack of available...
June 04, 2026 08:30 ET | Source: Fate Therapeutics, Inc.

Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting

FT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitals Continued...
June 04, 2026 08:00 ET | Source: Celularity Inc.

Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies

FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company pioneering...
June 04, 2026 08:00 ET | Source: Caseware

Trusted by the Majority of Top 30 U.S. Accounting Firms, Caseware Launches Verity Agentic Pioneer Program

The new program enables leading firms to build, deploy and govern proprietary AI agents on Caseware Verity.
June 04, 2026 08:00 ET | Source: Arvinas Inc.

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

NEW HAVEN, Conn., June 04, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced it has...